Immediate Impact

1 from Science/Nature 67 standout
Sub-graph 1 of 23

Citing Papers

Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia
2024 Standout
2 intermediate papers

Works of B.E. van den Borne being referenced

Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non–Small Cell Lung Cancer
2017
Effect of adenosine 5′-triphosphate infusions on the nutritional status and survival of preterminal cancer patients
2009

Author Peers

Author Last Decade Papers Cites
B.E. van den Borne 99 103 10 37 10 207
Alan C. Homans 88 32 37 23 13 257
Sanne de Wit 20 35 13 16 14 163
Janel Long‐Boyle 130 28 16 20 16 293
Gerald Hoke 93 82 26 20 15 241
Lindsay Lane 76 56 53 17 12 216
Yuya Shirai 53 88 13 26 13 187
D. Schweinitz 52 86 101 20 15 262
Kristen Whitaker 34 71 23 20 11 220
Gijs van Boxel 38 43 29 11 11 266
Ahmed Elghiaty 75 43 170 14 9 234

All Works

Loading papers...

Rankless by CCL
2026